Literature DB >> 18188659

Polymyalgia rheumatica/arteritis temporalis and acquired factor VIII inhibitor.

Marie Gallant1, Rik Lories, Johan Verbanck.   

Abstract

Acquired haemophilia is a rare, but often life-threatening bleeding disorder caused by autoantibodies, mostly directed against factor VIII (FVIII inhibitor). The incidence of acquired haemophilia, which most commonly affects patients over 50 years of age, is estimated between 0.2 and 1 million per year. Although its aetiology remains obscure, 40-50% of cases are associated with other conditions, such as pregnancy, malignancies, drugs and autoimmune disorders as rheumatoid arthritis, systemic lupus erythematosus and Sjögren's disease. We report the case of a 69-year-old patient with spontaneously acquired FVIII inhibitor secondary to polymyalgia rheumatica (PMR)/arteritis temporalis (AT). Our case illustrates that PMR/AT can be added to the list of autoimmune disorders associated with acquired haemophilia due to FVIII inhibitor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18188659     DOI: 10.1007/s10067-007-0817-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  6 in total

Review 1.  Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

Authors:  Julio Delgado; Victor Jimenez-Yuste; Fernando Hernandez-Navarro; Ana Villar
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

2.  Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.

Authors:  P A Holme; F Brosstad; G E Tjønnfjord
Journal:  Haemophilia       Date:  2005-09       Impact factor: 4.287

3.  Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.

Authors:  Y-W Huang; P Saidi; C Philipp
Journal:  Haemophilia       Date:  2004-11       Impact factor: 4.287

Review 4.  The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.

Authors:  Charles R M Hay; S Brown; P W Collins; D M Keeling; R Liesner
Journal:  Br J Haematol       Date:  2006-06       Impact factor: 6.998

Review 5.  Acquired factor VIII inhibitors: pathophysiology and treatment.

Authors:  Alice D Ma; Daniel Carrizosa
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

6.  A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.

Authors:  D Green; K Lechner
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

  6 in total
  1 in total

1.  Acquired Haemophilia Associated with Urticarial Vasculitis.

Authors:  Hassene Attout
Journal:  Eur J Case Rep Intern Med       Date:  2020-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.